Press Releases

Next-Generation Decision Support Software Introduces Predictive Clinical Tools for Gastroenterology, Rheumatology, Dermatology, and Pulmonology Fort Myers, FL - February 3, 2026 — Baysient®, a leader in precision medicine technology, today announced the commercial launch of iDose® GEN7.0, expanding its FDA-regulated…

Ft. Myers FL, February 28, 2020 - Baysient® LLC’s founder, Diane Mould, announces the release of the iDose® software technology platform version 1.0 for infliximab (an anti-inflammatory biologic drug), just before presenting Biologics and Precision Medicine in IBD at Canadian Digestive…